Bluejay Diagnostics, Inc. (NASDAQ:BJDX) Short Interest Update

Bluejay Diagnostics, Inc. (NASDAQ:BJDX) saw a significant drop in short interest in August. As of August 31st, there was short interest totalling 107,800 shares, a drop of 35.0% from the August 15th total of 165,800 shares. Based on an average daily trading volume, of 1,970,000 shares, the short-interest ratio is presently 0.1 days. Approximately 2.0% of the shares of the stock are short sold.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Bluejay Diagnostics stock. Armistice Capital LLC purchased a new position in shares of Bluejay Diagnostics, Inc. (NASDAQ:BJDX) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 24,230 shares of the company’s stock, valued at approximately $30,000. Armistice Capital LLC owned approximately 1.95% of Bluejay Diagnostics as of its most recent filing with the Securities and Exchange Commission (SEC). 18.47% of the stock is currently owned by institutional investors.

Bluejay Diagnostics Stock Performance

BJDX stock remained flat at $0.15 during midday trading on Friday. The company had a trading volume of 900,219 shares, compared to its average volume of 744,963. The stock has a market capitalization of $50,836.80, a PE ratio of 0.00 and a beta of 0.73. Bluejay Diagnostics has a 52-week low of $0.13 and a 52-week high of $48.80. The stock’s fifty day moving average is $0.38 and its 200-day moving average is $3.12.

Bluejay Diagnostics (NASDAQ:BJDX) last posted its earnings results on Wednesday, August 14th. The company reported ($5.12) earnings per share for the quarter.

About Bluejay Diagnostics

Bluejay Diagnostics, Inc, a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components.